ArticleThe Journal of experimental medicine2022

An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery.

Jiao Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.